Posted on 11/10/20
Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR) today reported its third quarter 2020 financial results, program progress and corporate updates.“During . . .
Posted on 11/9/20
Biohaven Reports Third Quarter 2020 Financial Results
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial . . .
Posted on 11/9/20
Scholar Rock Reports Third Quarter 2020 Financial Results and Highlights Business Progress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, . . .
Posted on 11/9/20
Sesen Bio Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported operating results . . .
Posted on 11/9/20
Seres Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., (Nasdaq: MCRB) today reported financial results from the third quarter ended September 30, 2020, and provided business updates.“Supported by our positive, . . .
Posted on 11/9/20
Morphic Announces Corporate Highlights and Third Quarter 2020 Financial Results
WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment . . .
Posted on 11/9/20
Baudax Bio Reports Third Quarter 2020 Financial Results
MALVERN, Pa., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today reported financial results . . .
Posted on 11/9/20
Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people . . .
Posted on 11/9/20
Allena Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
NEWTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat . . .
Posted on 11/9/20
Homology Medicines Announces $60 Million Equity Investment from Pfizer
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc. (NYSE: PFE) has agreed . . .
Posted on 11/9/20
Rubius Therapeutics Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an . . .
Posted on 11/9/20
Provident Healthcare Partners Advises Palmetto Retina Center In Its Partnership With Retina Consultants Of America
Palmetto Retina Center, comprised of five retina specialists across six offices serving South Carolina, has partnered with Retina Consultants of America (RCA), a portfolio company of . . .
Posted on 11/9/20
Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the third quarter ended . . .
Posted on 11/9/20
Seres Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., (Nasdaq: MCRB) today reported financial results from the third quarter ended September 30, 2020, and provided business updates.“Supported by our positive, . . .
Posted on 11/9/20
Decibel Therapeutics Raises $82M Series D
Decibel Therapeutics, a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, today announced the closing of an oversubscribed Series . . .
Posted on 11/9/20
Mersana Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates . . .
Posted on 11/9/20
LogicBio Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
LEXINGTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery . . .
Posted on 11/9/20
Moderna and Pfizer: A Tale of Two mRNA Coronavirus Vaccine Stocks
Ten programs are currently involved in phase 3 trials. But Moderna and Pfizer are arguably the closest to earning Emergency Use Authorizations (EUAs) for their vaccine . . .
Posted on 11/9/20
Here's Why Vertex Pharmaceuticals Fell 23.4% in October
What happenedShares of Vertex Pharmaceuticals (NASDAQ:VRTX) fell 23.4% in October, according to data from S&P Global Market Intelligence after the biotech discontinued development of a drug . . .
Posted on 11/6/20
CVS Health Reports Third Quarter Results
CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2020.CVS Health President and CEO Larry J. Merlo stated, "Our . . .
Posted on 11/6/20
Epizyme Reports Business Progress and Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today provided business and portfolio updates and reported third . . .
Posted on 11/6/20
Jounce Therapeutics Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 11/6/20
Epizyme Closes $150 Million Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that the company has entered into an . . .
Posted on 11/6/20
Biogen Changes The World And Grows 44%
SummaryBiogen had a dramatic day, after years of flip-flop, as it appears the company's new Aducanumab drug will be approved.Even outside of Aducanumab, the company has . . .
Posted on 11/6/20
Entasis Therapeutics Provides a Business Update
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel . . .
Boston
